Clinical Research Hamburg GmbH   Report issue

For profit Phase 2
Founded: Hamburg Germany (2004)

Organization Overview

First Clinical Trial
2015
NCT02479412
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Clinical Research Hamburg | Clinical Research Hamburg GmbH, Hamburg, Germany

Active Ingredients

Drugs in Phase 2 Trials (3)

abncov2 (1 trial)

albuterol (proventil) (1 trial)

Velsecorat (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3